TENKR
Closed
Tenx Keane Acquisition Right
0.48
+0.48 (0%)
Last Update: 07 Aug 2024 23:00:00
Yesterday: 0.
Day's Range: 0.48 - 0.5
Send
sign up or login to leave a comment!
When Written:
0.2451
TenX Keane Acquisition Right is a special purpose acquisition company (SPAC) formed by TenX Ventures, a venture capital firm. The purpose of the SPAC is to acquire a private company and take it public through a reverse merger.
Keane Acquisition Right is the name of the SPAC and it is listed on the NASDAQ under the ticker symbol "KANER". The SPAC raised $200 million in its initial public offering in December 2020.
TenX Ventures is led by CEO Michael Gelband, who previously worked at Millennium Partners and ExodusPoint Capital. The firm focuses on investing in technology companies in sectors such as fintech, healthcare, and artificial intelligence.
The specific target company that TenX Keane Acquisition Right plans to acquire has not been announced yet. However, the SPAC has stated that it is targeting a company in the technology or healthcare sector with an enterprise value of $1 billion or more.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Keane Acquisition Right is the name of the SPAC and it is listed on the NASDAQ under the ticker symbol "KANER". The SPAC raised $200 million in its initial public offering in December 2020.
TenX Ventures is led by CEO Michael Gelband, who previously worked at Millennium Partners and ExodusPoint Capital. The firm focuses on investing in technology companies in sectors such as fintech, healthcare, and artificial intelligence.
The specific target company that TenX Keane Acquisition Right plans to acquire has not been announced yet. However, the SPAC has stated that it is targeting a company in the technology or healthcare sector with an enterprise value of $1 billion or more.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








